Quality of life: clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of individuals withdrawing from treatment · people with ADHD and epilepsy
Omega‐3 (with risperidone and previous ASM) showed no clear difference in proportion of individuals withdrawing from treatment compared with risperidone and previous ASM only (low certainty).
1 finding from 1 review
Intervention not reported
Dual‐mobility total hip arthroplasty (No direct evidence, indirect evidence only) · older adults (> 60 years of age) with intracapsular hip fractures; most fractures in the included studies were displaced
It is very uncertain whether the intervention changes dual‐mobility total hip arthroplasty (No direct evidence, indirect… (very low certainty).
1 finding from 1 review
RR 0.64 [0.02, 17.67]
Studies not reported
Very low
Intervention not reported
Dual‐mobility total hip arthroplasty (No direct evidence, indirect evidence only) · older adults (> 60 years of age) with intracapsular hip fractures; most fractures in the included studies were displaced
It is very uncertain whether the intervention changes dual‐mobility total hip arthroplasty (No direct evidence, indirect… (very low certainty).
1 finding from 1 review
RR 1.07 [0.37, 3.14]
Studies not reported
Very low
Residual varicose veins · participants with varicose veinsa
It is very uncertain whether foam sclerotherapy changes residual varicose veins compared with liquid sclerotherapy (very low certainty).
1 finding from 1 review
Residual varicose veins · participants with varicose veinsb
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Residual varicose veins · participants with varicose veinsa
It is very uncertain whether foam sclerotherapy changes residual varicose veins compared with placebo (very low certainty).
1 finding from 1 review
Residual varicose veins · participants with varicose veinsa
Foam sclerotherapy showed no clear difference in residual varicose veins compared with foam sclerotherapy (moderate certainty).
1 finding from 1 review
Proportion of participants who experienced at least one AE and individual AEs · people with juvenile myoclonic epilepsy
1 finding from 1 review
Proportion of participants who experienced at least one AE and individual AEs · people with juvenile myoclonic epilepsy
1 finding from 1 review
Infection or inflammation at individual level (as measured by urinary neopterin, C‐reactive protein or alpha‐1‐acid glycoprotein variant A) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Infection or inflammation at individual level as measured by C‐reactive protein (CRP) (only in children 2 to 11 years of age) · general population of all age groups (including pregnant women) from any country, over two years of age
1 finding from 1 review
Post-operative pain (residual pain, any severity) · adults (> 18 years of age) with trigger finger
NSAID injection showed no clear difference in residual pain compared with glucocorticoid injection (low certainty).
1 finding from 1 review
Time after surgery to post‐void residual volume of urine ≤ 50 mL (days)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Post‐void residual urine volume (mL) at 1 month after surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time after surgery to post‐void residual volume of urine ≤ 50 mL (days)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Post‐void residual urine volume (mL) at 1 month after surgery
1 finding from 1 review
Quality of life: clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events as N of participants with at least one adverse event objective · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive functioning Clinically important change in cognitive functioning as defined by each study · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found